The role of thromboxane A2 (TxA2) in allergic cutaneous reactions and the effect of (E)-3-[p-(1H-Imidazol-1-ylmethyl) phenyl]-2-propenoic acid hydrochloride (OKY-046), a TxA2 synthetase inhibitor
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 35 (3), 125-130
- https://doi.org/10.1016/0952-3278(89)90112-9
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Pharmacological Studies on the TXA2 Synthetase Inhibitor (E)-3-[p(1H-lmidazol-1-Ylmethyl)Phenyl]-2-Propenoic Acid (OKY-046)The Japanese Journal of Pharmacology, 1986
- Pharmacological Characterization of Mouse Ear PCAInternational Archives of Allergy and Immunology, 1985
- The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammationJournal of Pharmacy and Pharmacology, 1983
- A selective inhibitor of thromboxane biosynthesis enhances immediate and inhibits late cutaneous allergic reactions in manJournal of Allergy and Clinical Immunology, 1983
- Characterization of imidazo[1,5-a]pyridine-5-hexanoic acid (CGS 13080) as a selective thromboxane synthetase inhibitor using in vitro and in vivo biochemical modelsBiochemical and Biophysical Research Communications, 1983
- UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activityThrombosis Research, 1981
- Selective inhibition of prostaglandin endoperoxide thromboxane isomerase by 1-carboxyalkylimidazolesProstaglandins, 1978
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969
- MEASUREMENT OF INFLAMMATION AND EVALUATION OF ANTI-INFLAMMATORY AGENTS1959